J
JBeam
Realizing a world where cancer is not scary with body-friendly BNCT
About JBeam
J BEAM INC., established in 2014 and headquartered in Fukushima Prefecture, specializes in leveraging neutron beam technology to develop cutting-edge products in the medical and industrial sectors. The company aims to contribute to societal development and post-earthquake reconstruction through its innovative solutions. One of its core focuses is Boron Neutron Capture Therapy (BNCT), a promising radiation therapy for cancer treatment. BNCT has the potential to offer radical treatment options for cancer, which remains a leading cause of death in Japan. J BEAM is working on making BNCT more accessible by developing systems that can be installed in many hospitals, overcoming the current limitation of requiring large-scale facilities. The company's business model revolves around research and development, product innovation, and partnerships with medical institutions and industrial clients. Revenue is generated through the sale and licensing of its advanced neutron beam technology solutions.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Japan
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Angel Bridge
SBI Investment
Future Venture Capital
Rohm
Series B and later4 investors entered at this stage
SMBC Venture Capital
Ci:z Investment
Astellas Venture
Japan Post Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about JBeam on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See JBeam on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.